Grannus Therapeutics
Indianapolis, US · Founded 2020 · United States corporation · 2 known investors
Grannus Therapeutics develops a new class of targeted cancer therapies. The company focuses on drug development for oncology patients.
BiotechHealthtech
Founders & leadership
JF
John FoglesongExecutive Officer, Director
JT
James ThompsonDirector
BB
Brian BlaggDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$800KraisedJan 2024 · 9 investors · BiotechnologyRule 506(b)
▶$800KraisedJan 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John FoglesongExecutive Officer, Director
- Brian BlaggDirector
- Offering amount
- $800K
- Amount sold
- $800K
- Minimum investment
- $250K
- First sale
- Nov 2023
- Incorporated
- Corporation, United States, 2020
- Federal exemptions
- 06b
▶$950KraisedJan 2022 · 11 investors · BiotechnologyRule 506(b)
▶$950KraisedJan 2022 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John FoglesongExecutive Officer, Director
- James ThompsonDirector
- Brian BlaggDirector
- Offering amount
- $1M
- Amount sold
- $950K
- Minimum investment
- $35K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.